The US pharmaceutical giant AbbVie and Danish biotechnology company Gubra, specializing in preclinical contract research services and peptide-based drug discovery within...
17.06.2019
- German drugmaker Boehringer Ingelheim and Danish biotech Gubra have announced a second collaboration and license agreement to develop novel poly-agonist peptides to treat obesity...
